Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases

A variety of inherited or multifactorial ocular diseases call for novel treatment paradigms. The newly developed genome editing technology, CRISPR, has shown great promise in treating these diseases, but delivery of the CRISPR/Cas components to target ocular tissues and cells requires appropriate us...

Full description

Saved in:
Bibliographic Details
Published inAdvanced drug delivery reviews Vol. 168; pp. 181 - 195
Main Authors Yu, Wenhan, Wu, Zhijian
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.01.2021
Subjects
Online AccessGet full text

Cover

Loading…